Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Threshold Pharmaceuticals)"
Count: 33
Selected: 0
NCT IDTitle
NCT03098160Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
NCT02454842Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC
NCT02449681Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS
NCT02093962Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
NCT02047500Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
NCT02020226A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
NCT01864538A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma
NCT01746979Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
NCT01522872Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
NCT01440088A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
NCT01381822Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
NCT01149915Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
NCT01144455Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
NCT00743379Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
NCT00742963Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
NCT00495144A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
NCT00435578Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
NCT00435448Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT00237536Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT00102752Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer
NCT00099294Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
NCT00096707Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
NCT00441467Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
NCT02712567SARC021C: A Continuation Study of TH-CR-406/SARC021
NCT02433639Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer
NCT02255110A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
NCT02076230A Phase 1 TH-302 Mass Balance Trial
NCT01833546A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer
NCT01721941TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma
NCT02598687Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
NCT02402062A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours
NCT01497444Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
NCT01485042Dose Escalation Study of Pazopanib Plus TH-302